Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evogene Ltd. Regulatory Filings 2016

Dec 30, 2016

6785_rns_2016-12-30_53c07f89-e57b-4d64-b764-5c3e9392ce21.htm

Regulatory Filings

Open in viewer

Opens in your device viewer

_________ false

����� ��"� 2 380
EVOGENE LTD
Corporation no: 512838723 10185
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 30/12/2016
www.isa.gov.il www.tase.co.il Reference: 2016-02-145465 Time of broadcast: 07:16 07:13:04

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on From 25 filed with the SEC
Form_25_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2016-02-140794
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 29/12/2016
Address: Gad Feinstein St 13, P.O.B 2100 , Rehovot 76121   , Tel: 08-9311900 , Fax: 08-9466724
E-mail address: [email protected]   Company site: www.evogene.com
Previous names of reporting entity:
Name of the Signatory: Shalem Merav Position of Signatory in the reporting corporation: Attorney/Legal Counsel Name of Employer Company:
Address: Gad Feinstein St. 13 , Rehovot 7612002 Telephone: 08-9311900 Facsimile: 08-9466724 E-mail: [email protected] 1